companydata.dkcompanydata.dk

AnRes Clinical ApS: Financial statements 2024

CVR: 41147504

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

AnRes Clinical ApS (CVR 41147504) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,445,527 and a net result of DKK 1,120,314 compared with DKK 116,961 the year before. That is an increase of 116.1% compared with the year before. Equity in the 2024 report amounted to DKK 2,149,763. The solvency ratio was 70.5%. The company had 2 employees in the financial year.

Gross Profit
DKK 2,445,527
Profit/Loss
DKK 1,120,314
Equity
DKK 2,149,763
Total Assets
DKK 3,051,152
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-2.4M1.1M2.1M2
2023-1.1M117K1.1M2
2022-1.4M102K973K3
2021-1.2M394K871K2
2020-806K438K478K2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

AnRes Clinical ApS: The 2023 annual report is outJun 11, 2024

AnRes Clinical ApS has published its annual report for 2023. Gross profit came to DKK 1,131,891, and the net result was DKK 116,961.

About AnRes Clinical ApS

AnRes Clinical ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Anna Katarzyna Polak. The company is owned by Anna Katarzyna Polak. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,457,177 and a net result of DKK 286,285 compared with DKK 1,120,314 the year before. Equity in the 2025 report amounted to DKK 2,306,048.

Source: annual report 2025, Danish Business Authority

Other financial years